Intelligent Bio Solutions (INBS) Short term Debt (2020 - 2022)
Intelligent Bio Solutions has reported Short term Debt over the past 3 years, most recently at $1.0 million for Q3 2022.
- Quarterly results put Short term Debt at $1.0 million for Q3 2022, up 1380.81% from a year ago — trailing twelve months through Sep 2022 was $1.0 million (up 1380.81% YoY), and the annual figure for FY2022 was $2.8 million, up 21190.87%.
- Short term Debt for Q3 2022 was $1.0 million at Intelligent Bio Solutions, down from $2.8 million in the prior quarter.
- Over the last five years, Short term Debt for INBS hit a ceiling of $5.1 million in Q2 2020 and a floor of $9536.0 in Q4 2021.
- Median Short term Debt over the past 3 years was $250214.5 (2020), compared with a mean of $1.2 million.
- Biggest five-year swings in Short term Debt: crashed 99.74% in 2021 and later skyrocketed 21190.87% in 2022.
- Intelligent Bio Solutions' Short term Debt stood at $431621.0 in 2020, then tumbled by 97.79% to $9536.0 in 2021, then soared by 10584.96% to $1.0 million in 2022.
- The last three reported values for Short term Debt were $1.0 million (Q3 2022), $2.8 million (Q2 2022), and $9536.0 (Q4 2021) per Business Quant data.